|
| | PD184352 Basic information |
| | PD184352 Chemical Properties |
| Melting point | 166-169°C | | density | 1.747±0.06 g/cm3(Predicted) | | storage temp. | room temp | | solubility | DMSO: ≥30mg/mL | | form | powder | | pka | -5.58±0.50(Predicted) | | color | white to tan |
| Hazard Codes | N | | Risk Statements | 50/53 | | Safety Statements | 60-61 | | RIDADR | UN 3077 9 / PGIII | | WGK Germany | 3 | | HS Code | 2924297099 |
| | PD184352 Usage And Synthesis |
| Chemical Properties | Off-White to Pale Beige Solid | | Uses | An inhibitor of ERK signaling pathway. A MAP kinase inhibitor. Potent MEK inhibitor. | | Definition | ChEBI: 2-(2-chloro-4-iodoanilino)-N-(cyclopropylmethoxy)-3,4-difluorobenzamide is an aminobenzoic acid. | | Biological Activity | pd184352 (also known as ci-1040), a benzhydroxamate derivative, is a potent and highly selective mek1/2, two members of the family of mapkks, inhibitor that inhibits purified mek1 with ic50 of 17 nm in a non-atp and non-erk1/2 competitive manner [1].pd184352 binds to a hydrophobic pocket, which is located in a region with low sequence homology to other kinases, adjacent to the mg-atp binding site of mek1 and mek2 inducing a conformational change in un-phosphorylated mek1/2 and hence inactivating the un-phosphorylated mek1/2 [1].pd184352 has been found to be actively against tumors, where it inhibits the growth of colon carcinomas in mouse xenograft models [1]. | | Biochem/physiol Actions | PD184352 (CI-1040) is a highly selective non-competitive inhibitor of MEK (MKK1; MAPK kinase) and the closely related MKK2. It has anti-cancer activity, suppresses the ERK pathway, and has been used along with other classes of inhibitors to establish embryonic stem cell lines. | | storage | Store at +4°C | | references | [1] frémin c, meloche s. from basic research to clinical development of mek1/2 inhibitors for cancer therapy. j hematol oncol. 2010 feb 11;3:8. doi: 10.1186/1756-8722-3-8. |
| | PD184352 Preparation Products And Raw materials |
|
